These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 19952936)

  • 1. Use of myocardin in the classification of mesenchymal tumors of the uterus.
    Liang J; Wu L; Xiao H; Li N; Wang H; Cheng C; Bai R; Zhao Y; Zheng H
    Int J Gynecol Pathol; 2010 Jan; 29(1):55-62. PubMed ID: 19952936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of histone deacetylase 8 (HDAC8), a new marker of smooth muscle differentiation, in the classification of mesenchymal tumors of the uterus.
    de Leval L; Waltregny D; Boniver J; Young RH; Castronovo V; Oliva E
    Am J Surg Pathol; 2006 Mar; 30(3):319-27. PubMed ID: 16538051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of oxytocin receptor expression in distinguishing between uterine smooth muscle tumors and endometrial stromal sarcoma.
    Loddenkemper C; Mechsner S; Foss HD; Dallenbach FE; Anagnostopoulos I; Ebert AD; Stein H
    Am J Surg Pathol; 2003 Nov; 27(11):1458-62. PubMed ID: 14576480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunohistochemical study of endometrial stromal sarcoma and smooth-muscle tumors of the uterus].
    Farah-Klibi F; Ben Hamouda S; Ben Romdhane S; Sfar R; Koubaa A; Ben Jilani S; Zermani R
    J Gynecol Obstet Biol Reprod (Paris); 2008 Sep; 37(5):457-62. PubMed ID: 18565690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of CD10 in distinguishing between endometrial stromal sarcoma and uterine smooth muscle tumors: an immunohistochemical comparison of 34 cases.
    Chu PG; Arber DA; Weiss LM; Chang KL
    Mod Pathol; 2001 May; 14(5):465-71. PubMed ID: 11353058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. h-Caldesmon expression effectively distinguishes endometrial stromal tumors from uterine smooth muscle tumors.
    Nucci MR; O'Connell JT; Huettner PC; Cviko A; Sun D; Quade BJ
    Am J Surg Pathol; 2001 Apr; 25(4):455-63. PubMed ID: 11257619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Myxoid mesenchymal tumors of uterus: endometrial stromal and smooth muscle tumors, myxoid variant].
    Chesnais AL; Watkin E; Beurton D; Devouassoux-Shisheboran M
    Ann Pathol; 2011 Jun; 31(3):152-8. PubMed ID: 21736994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of CD10 in malignant müllerian mixed tumors and adenosarcomas: an immunohistochemical study.
    Mikami Y; Hata S; Kiyokawa T; Manabe T
    Mod Pathol; 2002 Sep; 15(9):923-30. PubMed ID: 12218209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the O-linked N-acetylglucosamine containing epitope H in normal myometrium and uterine smooth muscle cell tumors.
    Sgantzos MN; Galani V; Arvanitis LD; Charchanti A; Psathas P; Nakou M; Havaki S; Kallioras V; Marinos E; Vamvakopoulos NC; Kittas C
    Pathol Res Pract; 2007; 203(1):31-7. PubMed ID: 17129677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. h-Caldesmon, a novel smooth muscle-specific antibody, distinguishes between cellular leiomyoma and endometrial stromal sarcoma.
    Rush DS; Tan J; Baergen RN; Soslow RA
    Am J Surg Pathol; 2001 Feb; 25(2):253-8. PubMed ID: 11176075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epithelioid smooth muscle tumors of the uterus do not express CD1a: a potential immunohistochemical adjunct in their distinction from uterine perivascular epithelioid cell tumors.
    Fadare O; Liang SX
    Ann Diagn Pathol; 2008 Dec; 12(6):401-5. PubMed ID: 18995203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An immunohistochemical analysis of endometrial stromal and smooth muscle tumors of the uterus: a study of 54 cases emphasizing the importance of using a panel because of overlap in immunoreactivity for individual antibodies.
    Oliva E; Young RH; Amin MB; Clement PB
    Am J Surg Pathol; 2002 Apr; 26(4):403-12. PubMed ID: 11914617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular mesenchymal tumors of the uterus: a review emphasizing recent observations.
    Oliva E
    Int J Gynecol Pathol; 2014 Jul; 33(4):374-84. PubMed ID: 24901397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IFITM1 Outperforms CD10 in Differentiating Low-grade Endometrial Stromal Sarcomas From Smooth Muscle Neoplasms of the Uterus.
    Busca A; Gulavita P; Parra-Herran C; Islam S
    Int J Gynecol Pathol; 2018 Jul; 37(4):372-378. PubMed ID: 28700435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative clinicopathologic and immunohistochemical analysis of uterine sarcomas diagnosed using the World Health Organization classification system.
    D'Angelo E; Spagnoli LG; Prat J
    Hum Pathol; 2009 Nov; 40(11):1571-85. PubMed ID: 19540555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic immunohistochemistry in uterine sarcomas: a study of 397 cases.
    Abeler VM; Nenodovic M
    Int J Gynecol Pathol; 2011 May; 30(3):236-43. PubMed ID: 21464730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bcl-2 receptor expression in patients with uterine smooth muscle tumors: an immunohistochemical analysis comparing leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma.
    Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K; Mayerhofer K
    J Soc Gynecol Investig; 2004 Apr; 11(3):187-91. PubMed ID: 15051039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mullerian adenosarcomas: an immunophenotypic analysis of 35 cases.
    Soslow RA; Ali A; Oliva E
    Am J Surg Pathol; 2008 Jul; 32(7):1013-21. PubMed ID: 18469708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. True smooth muscle tumors of the small intestine: a clinicopathologic, immunhistochemical, and molecular genetic study of 25 cases.
    Miettinen M; Sobin LH; Lasota J
    Am J Surg Pathol; 2009 Mar; 33(3):430-6. PubMed ID: 18971781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Low-grade leiomyosarcoma" and late-recurring smooth muscle tumors of the uterus: a heterogenous collection of frequently misdiagnosed tumors associated with an overall favorable prognosis relative to conventional uterine leiomyosarcomas.
    Veras E; Zivanovic O; Jacks L; Chiappetta D; Hensley M; Soslow R
    Am J Surg Pathol; 2011 Nov; 35(11):1626-37. PubMed ID: 21921786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.